Why AD still needs better solutions , IL-13, itch, and what makes lebrikizumab different

Free
Log In

Overview

eP2P on Atopic dermatitis disease area to be presented by: .
Dr. Dana Alessa 
Prof. Yousef Ben Amer 
Dr. Fares Alkhayal 
The whole session will be Chaired by Prof. Issam Hamada 


This Activity for

  • Resident / Fellow
  • Physician
  • Pharmacy
  • Clinical Pharmacy

What I will learn?

1 – Understand the heterogeneity of Atopic Dermatitis and Identify the Right Treatment for Right Patient
2 – Review the clinical benefits of lebrikizumab presenting clinical cases on AD


About Organizer

  • Virtual Medical Academy

Additional items to the activity

Optional Details Type Fee
Why AD still needs better solutions Certificate Certificate Free